Aleen Inc. is a healthcare technology company that develops artificial intelligence-powered tools for health assessment and symptom analysis. The company has created the Aleen AI system, which evaluates preliminary health conditions by analyzing user-provided information to deliver preliminary health insights. Aleen Inc. operates a software-as-a-service (SaaS) business model, generating revenue through API access packages that enable third-party developers and healthcare providers to integrate its AI capabilities into their own platforms. The company offers two distinct API service packages: API Integration and API calls, allowing clients to customize their level of access based on their needs. Founded in 2020 and headquartered in Toronto, Canada, Aleen Inc. serves a global market with significant revenue concentration in Turkey and the United Arab Emirates. The company operates within the Health Information Services industry, positioning itself as a provider of digital health infrastructure for clinical decision support and symptom screening applications. Its platform bridges the gap between consumers seeking preliminary health assessments and healthcare providers seeking to enhance their diagnostic workflows through artificial intelligence.
Markedsdata leveret af TwelveData og Morningstar